Reports
Sale
Global Nebulizer Market Share, Size, Analysis, Forecast: By Product Type: Jet Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer; By Portability: Digital Nebulizer, Analog Nebulizer; By Applications: COPD, Cystic Fibrosis, Asthma, Others; By End User: Hospitals, Clinics, Homecare Settings, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Nebulizer Market Outlook
The global nebulizer market size was valued at USD 1.14 billion in 2023, driven by the increasing prevalence of respiratory diseases across the globe. The market is expected to grow at a CAGR of 6% during the forecast period of 2024-2032, with the values likely to rise from USD 1.21 billion in 2024 to USD 1.93 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Nebulizer Market Overview
Nebulizers find their application to treat multiple indications such as asthma, COPD, and cystic fibrosis. Due to the high prevalence of smoking, and rapid industrialization, pollution levels are on the rise and there has been a significant upswing in respiratory disorders. Incidence of chronic diseases such as (chronic obstructive pulmonary disease) COPD is constantly on the rise and is expected to affect around 600 million people globally by 2050, leading to a substantial surge in the nebulizer market demand in the forecast period.
The market is driven by an increasing incidence of product launches focused on design improvements to offer customized and improved solutions to the patients. In addition, growing awareness of respiratory illnesses and the increasing accessibility of nebulizers are driving the growth along with Increasing investments by the key market players in the research and development of several new nebulizers with cutting-edge features.
Rising Prevalence for Portable Nebulizers
With increasing advancements in medical device manufacturing and a rising integration of novel technologies in the healthcare ecosystem, there has been significant nebulizer market growth with the development of new devices. In January 2023, Synergy Life Science, Inc., launched Nebi, the first battery operated and compact nebuliser to be used for multiple respiratory indications. To beat the issues related to conventional nebulizers, the new device is equipped with a rechargeable battery, and is based on interchangeable, and replaceable cartridges. It can also be used in cannabis, wellness, and smoking cessation therapies and possesses the potential to be used in multiple treatments.
Surge Research Activities to Develop IoT based Nebulizers and Boost Nebulizers Market Share
To offer precise and timely drug dosage, scientists have developed an IoT based nebulizer which work by providing an intelligent airflow. Breath Enhanced Technology (BET) is used in modern commercial nebulizers, as it offers controlled drug delivery and monitors asthma attacks with respect to frequency and time. With prompt monitoring, patients can receive improved treatment and prevention from fatal complications as well. The new technology offers an advantage over normal circuits, which are a more tedious process to manage.
Increasing Investments to Develop New Devices
In October 2022, Qnovia secured USD 17 million funding to develop an effective nicotine replacement therapy for humans with the help of a breath-activated, hand-held vibrating mesh nebulizer that generates aerosol for inhalation. The rising investments to bring improved and effective patient outcomes to poised to expand the nebulizer market size in the forecast period. The company aimed at developing an effective device that offers precise dosage along with optimal delivery to the lungs. With multiple partnerships, the company also plans to expand their research and offer treatment for multiple respiratory indications.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Nebulizer Market Segmentation
Market Breakup by Product Type
- Jet Nebulizer
- Ultrasonic Nebulizer
- Mesh Nebulizer
Market Breakup by Portability
- Digital Nebulizer
- Analog Nebulizer
Market Breakup by Applications
- COPD
- Cystic Fibrosis
- Asthma
- Others
Market Breakup by End User
- Hospitals
- Clinics
- Homecare Settings
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Nebulizer Market Regional Analysis
The United States is expected to lead the market share in coming years. The market share can be attributed to a robust medical and research infrastructure. The presence of prominent healthcare companies, along with academic and research institutions, plays a pivotal role in driving the market value.
In the forecast period, Asia Pacific region is poised to experience significant nebulizer market growth, with countries like China, India, and Japan emerging as the biggest markets. The growth can be attributed to the increasing prevalence of respiratory disorders such as COPD, asthma, and cystic fibrosis and rising merger activities between native and international companies. For instance, AeroRx Therapeutics (a United States based inhalation company) and a Taiwan based startup, HCmed Innovations collaborated to develop a breath-actuated nebulizer in combination with LABA/LAMA (long-acting muscarinic antagonist/long-acting beta agonist).
Global Nebulizer Market: Competitor Landscape
In June 2023, Liquidia Corporation and Pharmosa Biopharm announced their collaboration to develop and commercialise L606, a controlled release and inhalation-based formulation of Treprostinil, under clinical trial evaluation for treating pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The collaboration is anticipated to cost around USD 10 million and as per the terms of agreement, Liquidia is expected to develop and take control of the regulatory and commercial activities while Pharmosa will help in establishing a global supply chain and manufacture clinical and commercial supplies. The market has been witnessing several mergers and acquisitions amongst developed and budding organizations to diversify their product portfolio and establish a solid market presence.
The key features of the nebulizer market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Adherium
- AstraZeneca
- Boehringer Ingelheim International GmbH
- Cohero Health, Inc.
- GSK Group of Companies
- Teva Pharmaceutical Industries Limited
- Vectura Group Ltd.
- Propeller Health
- Novartis AG
- OPKO Health Inc.
- AptarGroup, Inc.
- Sensirion AG
- Teleflex Medical, Inc.
- Trudell Medical International
- Briggs Healthcare
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Portability |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nebulizer Market Overview
3.1 Global Nebulizer Market Historical Value (2017-2023)
3.2 Global Nebulizer Market Forecast Value (2024-2032)
4 Global Nebulizer Market Landscape
4.1 Global Nebulizer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nebulizer Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Portability
4.2.3 Analysis by Applications
5 Global Nebulizer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nebulizer Market Segmentation (2017-2032)
6.1 Global Nebulizer Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Jet Nebulizer
6.1.3 Ultrasonic Nebulizer
6.1.4 Mesh Nebulizer
6.2 Global Nebulizer Market (2017-2032) by Portability
6.2.1 Market Overview
6.2.2 Digital Nebulizer
6.2.3 Analog Nebulizer
6.3 Global Nebulizer Market (2017-2032) by Applications
6.3.1 Market Overview
6.3.2 COPD
6.3.3 Cystic Fibrosis
6.3.4 Asthma
6.3.5 Others
6.4 Global Nebulizer Market By End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Homecare Settings
6.4.5 Others
6.5 Global Nebulizer Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Nebulizer Market (2017-2032)
7.1 North America Nebulizer Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Jet Nebulizer
7.1.3 Ultrasonic Nebulizer
7.1.4 Mesh Nebulizer
7.2 North America Nebulizer Market (2017-2032) by Portability
7.2.1 Market Overview
7.2.2 Digital Nebulizer
7.2.3 Analog Nebulizer
7.3 North America Nebulizer Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Nebulizer Market (2017-2032)
8.1 Europe Nebulizer Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Jet Nebulizer
8.1.3 Ultrasonic Nebulizer
8.1.4 Mesh Nebulizer
8.2 Europe Nebulizer Market (2017-2032) by Portability
8.2.1 Market Overview
8.2.2 Digital Nebulizer
8.2.3 Analog Nebulizer
8.3 Europe Nebulizer Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Nebulizer Market (2017-2032)
9.1 Asia Pacific Nebulizer Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Jet Nebulizer
9.1.3 Ultrasonic Nebulizer
9.1.4 Mesh Nebulizer
9.2 Asia Pacific Nebulizer Market (2017-2032) by Portability
9.2.1 Market Overview
9.2.2 Digital Nebulizer
9.2.3 Analog Nebulizer
9.3 Asia Pacific Nebulizer Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Others
10 Latin America Nebulizer Market (2017-2032)
10.1 Latin America Nebulizer Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Jet Nebulizer
10.1.3 Ultrasonic Nebulizer
10.1.4 Mesh Nebulizer
10.2 Latin America Nebulizer Market (2017-2032) by Portability
10.2.1 Market Overview
10.2.2 Digital Nebulizer
10.2.3 Analog Nebulizer
10.3 Latin America Nebulizer Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Nebulizer Market (2017-2032)
11.1 Middle East and Africa Nebulizer Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Jet Nebulizer
11.1.3 Ultrasonic Nebulizer
11.1.4 Mesh Nebulizer
11.2 Middle East and Africa Nebulizer Market (2017-2032) by Portability
11.2.1 Market Overview
11.2.2 Digital Nebulizer
11.2.3 Analog Nebulizer
11.3 Middle East and Africa Nebulizer Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Adherium
17.1.1 Company Overview
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 AstraZeneca
17.2.1 Company Overview
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boehringer Ingelheim International GmbH
17.3.1 Company Overview
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cohero Health, Inc.
17.4.1 Company Overview
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 GSK Group of Companies
17.5.1 Company Overview
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teva Pharmaceutical Industries Limited
17.6.1 Company Overview
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Vectura Group Ltd.
17.7.1 Company Overview
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Propeller Health
17.8.1 Company Overview
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Novartis AG
17.9.1 Company Overview
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 OPKO Health Inc.
17.10.1 Company Overview
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 AptarGroup, Inc.
17.11.1 Company Overview
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Sensirion AG
17.12.1 Company Overview
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Teleflex Medical, Inc.
17.13.1 Company Overview
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Trudell Medical International
17.14.1 Company Overview
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Briggs Healthcare
17.15.1 Company Overview
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Nebulizer Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.14 billion in 2023, driven by the growing incidence of respiratory diseases across the globe.
The market is anticipated to grow at a CAGR of 6% during the forecast period of 2024-2032, likely to reach a market value of USD 1.93 billion by 2032.
The market demand is driven by rising prevalence of pollution levels, smoking, rapid industrialisation, and the growing geriatric population. Increasing awareness initiatives, convergence of smart technologies into developing new products and investments by key market players are also fuelling market demand.
The advent of technically advanced products to offer prompt and effective outcomes for patients is a major market trend. In January 2023, Synergy Life Science, Inc., launched Nebi, the first battery operated, rechargeable, pocket sized, and compact nebuliser to be used for multiple respiratory indications.
Based on product types, the market is divided into jet, ultrasonic, and mesh nebulizer.
Common application areas include COPD, cystic fibrosis, asthma, and others.
It includes digital as well as analog nebuliser.
Major end users include hospitals, clinics, and homecare settings, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Adherium, AstraZeneca, Boehringer Ingelheim International GmbH, Cohero Health, Inc., GSK Group of Companies, Teva Pharmaceutical Industries Limited, Vectura Group Ltd., Propeller Health, Novartis AG, OPKO Health Inc., AptarGroup, Inc., Sensirion AG, Teleflex Medical, Inc., Trudell Medical International and Briggs Healthcare.
Analyst Review
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER